Norris Medicines Ltd. - Research Center
524414 NORRIS Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 3.50 | 3.98 | 2.35 | 7.09 | 5.01 |
| Operating profit | -0.63 | 0.04 | -0.46 | 0.39 | -0.82 |
| Interest | 0.17 | 0.74 | 0.56 | 0.92 | 0.39 |
| Gross profit | -0.80 | -0.70 | -1.01 | -0.52 | -1.19 |
| EPS (Rs) | -1.10 | -1.01 | -2.44 | -0.85 | -1.56 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | - | - | 0.01 | 0.02 | 0.02 |
| Stock adjustment | -0.03 | -0.58 | 0.01 | 2.03 | 0.69 |
| Raw material | 2.41 | 2.53 | 1.17 | 2.40 | 2.86 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.07 | 1.05 | 1.03 | 1.30 | 1.29 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.67 | 0.95 | 0.60 | 0.98 | 1.00 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.29 | 0.30 | 0.33 | 0.32 | 0.36 |
| Taxation | - | - | 1.08 | - | - |
| Net profit / loss | -1.09 | -1.00 | -2.42 | -0.84 | -1.55 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -18.01 | 1.04 | -19.54 | 5.45 | -16.41 |
| GPM (%) | - | - | -42.77 | -7.32 | -23.56 |
| NPM (%) | - | - | -102.75 | -11.86 | -30.71 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis